4//SEC Filing
McClellan William D. Jr. 4
Accession 0001209191-23-035833
CIK 0001358762other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:20 PM ET
Size
11.3 KB
Accession
0001209191-23-035833
Insider Transaction Report
Form 4
McClellan William D. Jr.
Director
Transactions
- Award
Class A common stock
2023-06-07$93.61/sh+1,682$157,452→ 6,017 total - Award
Stock Option (right-to-buy)
2023-06-07+2,137→ 2,137 totalExercise: $93.61Exp: 2033-06-07→ Class A common stock (2,137 underlying) - Award
Class A common stock
2023-06-07$93.61/sh+106$9,923→ 4,335 total - Award
Stock Option (right-to-buy)
2023-06-07$73.68/sh+135$9,947→ 135 totalExercise: $93.61Exp: 2033-06-07→ Class A common stock (135 underlying)
Footnotes (4)
- [F1]The shares represent Restricted Stock Units (RSUs), which vest on June 5, 2024, subject to continued service through the vesting date.
- [F2]These RSUs were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $9,923.
- [F3]The option vests in 4 equal installments on September 7, 2023, December 7, 2023, March 7, 2024, and June 5, 2024, subject to continued service through each vesting date.
- [F4]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $9,947.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001689402
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:20 PM ET
- Size
- 11.3 KB